Would you consider hormone replacement therapy in young women with germline BRCA1 mutation and history of triple negative breast cancer who underwent bilateral mastectomy and prophylactic bilateral salpingo-oophorectomy?   

This situation can feel uncomfortable.  Would this feel safer if patient is s/p mastectomy and had TNBC?

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist
Finkelstein et al., PMID: 18160467. “The mo...
Medical Oncologist at Northwestern Medicine Cancer Center at KishHealth
Updated results from the women's health initiative...
Sign in or Register to read more